We caught up with two of our researchers about how COVID-19 has impacted their work, and what the next few months looks like for them.
The UK Government has announced a new “landmark” obesity strategy that will aid our ambition to beat cancer.
Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string’ test to detect oesophageal cancer earlier.
The UK Government have launched a new obesity strategy with a raft of measures, including restricting junk food marketing on TV and online.
Researchers have developed a new blood test that can detect cancers in blood samples taken up to 4 years before diagnosis.
Estimating the impact of COVID-19 on cancer survival is not an easy thing to do.
Smoking could be banned outsides pubs, cafés and restaurants in England, with peers urging ministers to consider similar measures in England.
We caught up with 3 people living with cancer to find out how the coronavirus pandemic has affected them and their families.
We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell.
The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.